This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Oil & Gas Stock Roundup: Oilfield Service Giants Decide to Move From Russia
by Nilanjan Choudhury
Apart from Russia-related updates from Halliburton (HAL), Schlumberger (SLB) and Core Laboratories (CLB), there was news regarding The Williams Companies (WMB) and Eni (E) during the week.
Core Labs (CLB) Hit by Russia Conflict, Pegs Down Q1 View
by Zacks Equity Research
In addition to the geopolitical risks, Core Laboratories (CLB) suffered operational hiccups after a much larger-than-usual number of its employees tested positive for COVID during the first quarter.
Core Laboratories (CLB) Moves 14.2% Higher: Will This Strength Last?
by Zacks Equity Research
Core Laboratories (CLB) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Why Is Core Laboratories (CLB) Up 7.1% Since Last Earnings Report?
by Zacks Equity Research
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Core Labs (CLB) Q4 Earnings Meet Estimates, Revenues Surpass
by Zacks Equity Research
Core Laboratories' (CLB) fourth-quarter earnings are on par with the consensus mark, while revenues beat estimates as a result of a strong performance in the Production Enhancement segment.
Core Laboratories (CLB) Meets Q4 Earnings Estimates
by Zacks Equity Research
Core Laboratories (CLB) delivered earnings and revenue surprises of 0% and 1.52%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Core Laboratories (CLB) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Schlumberger (SLB) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Schlumberger (SLB) delivered earnings and revenue surprises of 5.13% and 2.14%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
ExxonMobil (XOM) to Divest Iraq Assets After Receiving Approval
by Zacks Equity Research
ExxonMobil's (XOM) divestment of its West Qurna 1 stake would follow its 32% interest sale last year in a key exploration block in Iraq's Kurdistan region.
Core Labs' (CLB) Stock Up 9.4% Despite Missing on Q3 Earnings
by Zacks Equity Research
In the September quarter, Core Labs (CLB) generates $11.9 million as operating cash and its capex totals $3.1 million, leading to an $8.8-million free cash flow (FCF) recognition.
Core Laboratories (CLB) Q3 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Core Laboratories (CLB) delivered earnings and revenue surprises of -5.26% and -4.00%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Core Laboratories (CLB) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Is Core Laboratories (CLB) Down 19.4% Since Last Earnings Report?
by Zacks Equity Research
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Core Labs' (CLB) Q2 Earnings and Revenues Miss Estimates
by Zacks Equity Research
In the June quarter, Core Labs (CLB) generates $9.5 million in operating cash and its capital expenditure totals $2.9 million, leading to a $6.6-million free cash flow (FCF) recognition.
Core Laboratories (CLB) Lags Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Core Laboratories (CLB) delivered earnings and revenue surprises of -5.26% and -0.09%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Core Laboratories (CLB) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Schlumberger (SLB) Stock Jumps 7.7% on Uplifting Forecasts
by Zacks Equity Research
Schlumberger (SLB) expects oil activities to improve in the coming days, which in turn is likely to boost the demand for oilfield services.
Core Laboratories (CLB) Up 33.5% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Core Labs' (CLB) Q1 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
In the March quarter, Core Labs (CLB) generates $8 million in operating cash and its capital expenditure totals $2.8 million, leading to a $5.2-million free cash flow (FCF) recognition.
Core Laboratories (CLB) Q1 Earnings Top Estimates
by Zacks Equity Research
Core Laboratories (CLB) delivered earnings and revenue surprises of 15.38% and -1.61%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Core Laboratories (CLB) Q1 Earnings Expected to Decline
by Zacks Equity Research
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Core Labs' (CLB) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
In the December quarter, Core Labs (CLB) generates $57.9 million in operating cash and its capital expenditure totals $11.9 million, leading to a $46-million free cash flow (FCF) recognition.
Core Laboratories (CLB) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Core Laboratories (CLB) delivered earnings and revenue surprises of 5.88% and 3.33%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Core Laboratories (CLB) in Q4 Earnings?
by Zacks Equity Research
Core Laboratories' (CLB) cost-saving measures are expected to have driven fourth-quarter earnings and cash flows higher.
What's in Store for Oilfield Service in Q4 Earnings?
by Nilanjan Banerjee
Cost-cutting measures and demand recovery for oilfield equipment & services have likely aided companies belonging to the oilfield service space in Q4. SLB, BKR & CLB are yet to report earnings.